The Cas­sa­va saga con­tin­ues as test­ing part­ner de­nies prepar­ing taint­ed Alzheimer's da­ta

4 years ago
R&D

Covid-19 roundup: Blood clot risk much high­er from dis­ease than vac­cines — study; Brazil OKs In­ovio PhI­II tri­al

4 years ago
Coronavirus

Bank­rupt­cy judge: J&J can spin talc pow­der in­to dif­fer­ent com­pa­ny, po­ten­tial­ly slow­ing plain­tiff­s' pay­outs

4 years ago
Pharma

Ap­peals court sides with Gilead, Kite in CAR-T patent brawl, void­ing Bris­tol My­ers’ big $1.2B award

4 years ago
Pharma
Cell/Gene Tx

CBO warns of al­most 60 few­er new drugs over three decades with Medicare drug ne­go­ti­a­tions bill

4 years ago
Pharma

Covid-19 man­u­fac­tur­ing roundup: Pro­duc­tion ramp-ups ap­proved by EU; mR­NA boom spurs Lon­za­'s Chi­nese ex­pan­sion

4 years ago
Coronavirus
Manufacturing

Bio­Duro-Sun­dia plants its flag at for­mer Par man­u­fac­tur­ing site in CA

4 years ago
Outsourcing
Manufacturing

WuXi Bi­o­log­ics earns lo­cal nod for ex­pan­sion to grow­ing MA man­u­fac­tur­ing site

4 years ago
Manufacturing

Cipla re­opens South African man­u­fac­tur­ing site af­ter vi­o­lent protests

4 years ago
Manufacturing

Play­ing a sur­pris­ing­ly hot hand, Be­yond­Spring nails a $200M Chi­na deal in wake of a piv­otal suc­cess

4 years ago
Deals
China

Kevin Ju­dice plays DiCE, piv­ot­ing from a $60M raise straight to the big S-1 fil­ing

4 years ago
Financing

Am­neal touts re­sults from Phase III tri­al in Parkin­son's; No­vaRock part­ners on can­cer drug

4 years ago
News Briefing

FDA faults Japan­ese man­u­fac­tur­er with da­ta breach, con­t­a­m­i­nat­ed in­jecta­bles

4 years ago
FDA+
Manufacturing

As­cendis wins ap­proval for once-week­ly growth hor­mone drug as Pfiz­er, Op­ko Health keep up the pres­sure

4 years ago
FDA+

On­colyt­ic play­er abrupt­ly ter­mi­nates CMO, on­ly a year in, and elim­i­nates the job

4 years ago
People

Pfiz­er inks Latin Amer­i­can dis­tri­b­u­tion deal for now ful­ly ap­proved Covid-19 vac­cine

4 years ago
Coronavirus
Manufacturing

ADC Ther­a­peu­tics sells off roy­al­ty share for lead an­ti­body-drug con­ju­gate in $325M deal

4 years ago
Deals

Opin­ion: Pfiz­er vac­cine's 3-month full ap­proval, and less than 1-month sBLA OK — is the FDA's 'gold stan­dard' ...

4 years ago
FDA+

Al­bert Bourla picks a new deal­mak­er to lead the hunt for more drugs to swell Pfiz­er’s pipeline

4 years ago
Deals
R&D

Af­ter pan­dem­ic de­lay and a South Ko­re­an deal, Boston-area biotech rais­es Se­ries B with sights on IPO

4 years ago
Financing

On the back of PhI­II suc­cess, As­traZeneca lays out the red car­pet for rare dis­ease drug Alex­ion paid $855M for

4 years ago
R&D

Covid-19 roundup: Biden now plans boost­ers af­ter 6 months as Pfiz­er sub­mits sBLA; 1.6M Mod­er­na dos­es con­t­a­m­i­nat­ed in ...

4 years ago
Coronavirus

Days af­ter a CRL and damn­ing re­ports of tri­al mis­con­duct, a trou­bled biotech beats a hasty re­treat from Eu­rope

4 years ago
R&D
FDA+

Chi­nese phar­ma groups part­ner in $150M li­cens­ing deal; Pfiz­er to join law­suit on tar­iffs

4 years ago
News Briefing
First page Previous page 646647648649650651652 Next page Last page
A service from the Financial Times